Microbot Medical Inc MBOT

Morningstar Rating

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MBOT is trading at a LOCK|&>lFJ premium.
Price
$1.07
Fair Value
LOCK|^L>M!^
Uncertainty
LOCK|dP hLQ&%
1-Star Price
LOCK|y%jfy#
5-Star Price
LOCK|@^gVf^
Economic Moat
LOCK|^$
Capital Allocation
—

Trading Information

Previous Close Price
—
Day Range
—–—
52-Week Range
—–—
Bid/Ask
— / —
Shares Outstanding
67.16M
Market Cap
—
Volume/Avg
— / —

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
193.18
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
22

Valuation

Metric
MBOT
Price/Earnings (Normalized)
—
Price/Book Value
1.04
Price/Sales
193.18
Price/Cash Flow
—
Price/Earnings
MBOT

Financial Strength

Metric
MBOT
Quick Ratio
17.37
Current Ratio
18.56
Interest Coverage
—
Quick Ratio
MBOT

Profitability

Metric
MBOT
Return on Assets (Normalized)
−21.73%
Return on Equity (Normalized)
−22.97%
Return on Invested Capital (Normalized)
−25.97%
Return on Assets
MBOT

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|$@?l>^LOCK|Dd#s$172B
Medtronic PLC
MDT
LOCK|FpNp@<WLOCK|RG!@$113B
Stryker Corp
SYK
LOCK|>%K^z@$LOCK|vnx$106B
Boston Scientific Corp
BSX
LOCK|#N$Cm&@LOCK|^nFs$62B
Edwards Lifesciences Corp
EW
LOCK|!z@Y?cghLOCK|dsq#c$49B
DexCom Inc
DXCM
LOCK|^$!Yl%?LOCK|<CRP$32B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|mMdRYQDLOCK|qj$30B
Koninklijke Philips NV ADR
PHG
LOCK|r&$LOCK|?%m$24B
Steris PLC
STE
LOCK|ym$$&pLOCK|lhbK?$21B
Zimmer Biomet Holdings Inc
ZBH
LOCK|N&P?Tf?qLOCK|y!$17B

Sponsor Center